What are the criteria for determining high-risk individuals prior to preexposure prophylaxis (PrEP) for HIV?

Updated: Oct 08, 2019
  • Author: Alejandro Delgado, MD; Chief Editor: Michael Stuart Bronze, MD  more...
  • Print


When considering emtricitabine/tenofovir for PrEP it is important to identify individuals at high risk. High-risk patients include those who have partner(s) known to be HIV-1 infected, or who engage in sexual activity within a high prevalence area or social network and exhibit one or more of the following: inconsistent or no condom use, diagnosis of sexually transmitted infections, exchange of sex for commodities (such as money, food, shelter, or drugs), use of illicit drugs or alcohol dependence, or incarceration partner(s) of unknown HIV-1 status with any of the factors listed above.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!